In the Karlskrona RA study, the corresponding values were IgG anti-RgpB in serum (p = 0.373), IgA anti-RgpB in serum (p = 0.145), and IgA anti-RgpB in saliva (p = 0.240). Here, CD79A is linked to rheumatoid arthritis.